Akademisyen
MÜZEYYEN ASLANER
DOÇENT
ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 28
- Proje 0
- Kitap 14
- Bildiri 73
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
3
Q2
4
Q3
18
Q4
2
WoS (JCR)
Q1
4
Q2
2
Q3
10
Q4
13
TR Index
14
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
0
Ort. yüzdelik
40.9%
Üst %1 payı
0.0%
Üst %10 payı
0.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Dermatology Consultations From the Hematology Department: A Retrospective Single-Center Analysis YÖKSİS SJR Q1 JCR Q4 OpenAlex 37.2%
- 2025 Evaluation of cholesterol levels in hematological malignancies YÖKSİS OpenAlex 11.4%
- 2024 Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group. YÖKSİS SJR Q2 JCR Q1 OpenAlex 23.0%
- 2024 Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program YÖKSİS SJR Q1 JCR Q1
- 2023 Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 71.8%
- 2023 The Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients With LowRisk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 3.0%
- 2023 Non-Hodgkin Lenfoma Olgularının Geriye Dönük Değerlendirilmesi: Tek Merkez Deneyimi YÖKSİS OpenAlex 9.5%
- 2022 Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study. YÖKSİS SJR Q2 JCR Q2 OpenAlex 63.9%
- 2022 Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case YÖKSİS SJR Q3 JCR Q4 OpenAlex 54.6%
- 2022 Multiple muscle involvement in relapsed multiple myeloma: A rare case YÖKSİS SJR Q3 JCR Q4 OpenAlex 47.9%
- 2022 The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study. YÖKSİS SJR Q3 JCR Q4 OpenAlex 63.6%
- 2022 Quadruple Therapy in Patients with Immune Thrombocytopenia YÖKSİS TR Index JCR Q3 OpenAlex 48.9%
- 2021 Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 19.6%
- 2021 Non-Hodgkin Lenfomalı Hastalarda Hepatit B Prevalansının Değerlendirilmesi ve Profilaksinin Yeri YÖKSİS OpenAlex 52.6%
- 2021 Abnormalities of Peripheral Blood Parameters in Hospitalized Patients with COVID-19: A Temporal Change Analysis in Relation to Survival YÖKSİS TR Index OpenAlex 17.2%
- 2021 The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients YÖKSİS OpenAlex 45.7%
- 2019 A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 78.2%
- 2016 A case of Langerhans Cell Histiocytosis with Multisystemic Involvement in an Adult Patient YÖKSİS TR Index SJR Q4 JCR Q3 OpenAlex 8.2%
- 2024 Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group YÖKSİS SJR Q2 JCR Q1 OpenAlex 23.0%
- 2024 Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program YÖKSİS SJR Q1 JCR Q1